This oncogenic function of CELF2 contrasts with its repressive effect on cell proliferation previously reported in various cancers such as breast cancer, non-small-cell lung carcinoma or even glioma, where CELF2 is underexpressed [20,21,22,23,24]. This evidence concerns the gene CELF2 and central nervous system cancer.